EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation

Graziela Perri, Vanessa Garcia Vilas Boas, Maria Renata Sales Nogueira, Edgard José Franco Mello Júnior, Ana Lucia Coelho, Edwin M Posadas, Cory Hogaboam, Karen A Cavassani, Ana Paula Campanelli

Cancer Immunology, Immunotherapy · 2024

DOI: 10.1007/s00262-024-03676-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2024. Verfasst von Graziela Perri und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo, Al. Dr. Octávio Pinheiro Brisolla, Bauru, SP, 17012-901, Brazi…. Hauptthemen laut MEDLINE: Interleukin-33, Cell Proliferation, Cell Movement, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interleukin (IL)-33 is an important cytokine in the tumour microenvironment; it is known to promote the growth and metastasis of solid cancers, such as gastric, colorectal, ovarian and breast cancer. Our group demonstrated that the IL-33/ST2 pathway enhances the development of squamous cell carcinoma (SCC). Conversely, other researchers have reported that IL-33 inhibits tumour progression. In addition, the crosstalk between IL-33, cancer cells and immune cells in SCC remains unknown. The aim of this study was to investigate the effect of IL-33 on the biology of head and neck SCC lines and to evaluate the impact of IL-33 neutralisation on the T cell response in a preclinical model of SCC. First, we identified epithelial and peritumoural cells as a major local source of IL-33 in human SCC samples. Next, in vitro experiments demonstrated that the addition of IL-33 significantly increased the proliferative index, motility and invasiveness of SCC-25 cells, and downregulated MYC gene expression in SCC cell lines. Finally, IL-33 blockade significantly delayed SCC growth and led to a marked decrease in the severity of skin lesions. Importantly, anti-IL-33 monoclonal antibody therapy increase the percentage of CD4 + IFNγ + T cells and decreased CD4 + and CD8 + T cells secreting IL-4 in tumour-draining lymph nodes. Together, these data suggest that the IL-33/ST2 pathway may be involved in the crosstalk between the tumour and immune cells by modulating the phenotype of head and neck SCC and T cell activity. IL-33 neutralisation may offer a novel therapeutic strategy for SCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-33Cell ProliferationCell MovementCarcinoma, Squamous CellLymphocyte ActivationHumansAnimalsNeoplasm InvasivenessMiceCell Line, TumorHead and Neck NeoplasmsT-LymphocytesTumor MicroenvironmentFemale

Stichwörter der Autor:innen

IL-33InvasionMotilityProliferationSquamous cell carcinoma

Substanzen

Interleukin-33IL33 protein, human

Autor:innen und Institutionen

  • Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo, Al. Dr. Octávio Pinheiro Brisolla, Bauru, SP, 17012-901, Brazil.
  • Research and Teaching Division, State Department of Health, Instituto Lauro de Souza Lima, Bauru, SP, Brazil.
  • Department of Medicine, Division of Pulmonary and Critical Care Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
  • Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
  • Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo, Al. Dr. Octávio Pinheiro Brisolla, Bauru, SP, 17012-901, Brazil. apcampan@usp.br.

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Zitieren

APA

Perri, G., Vilas Boas, V. G., Nogueira, M. R. S., Mello Júnior, E. J. F., Coelho, A. L., Posadas, E. M., Hogaboam, C., Cavassani, K. A., & Campanelli, A. P. (2024). Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-024-03676-8

Vancouver

Perri G, Vilas Boas VG, Nogueira MRS, Mello Júnior EJF, Coelho AL, Posadas EM, et al. Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation. Cancer Immunology, Immunotherapy. 2024. doi:10.1007/s00262-024-03676-8

BibTeX
@article{Perri2024,
  author = {Perri, Graziela and Vilas Boas, Vanessa Garcia and Nogueira, Maria Renata Sales and Mello Júnior, Edgard José Franco and Coelho, Ana Lucia and Posadas, Edwin M and Hogaboam, Cory and Cavassani, Karen A and Campanelli, Ana Paula},
  title = {Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2024},
  doi = {10.1007/s00262-024-03676-8}
}
Kostenlos starten →